Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare haematology
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sickle Cell Disease treatment
Novartis partners with American Society of Hematology to fight Sickle Cell Disease in Sub-Saharan…
Six African nations will join a partnership pioneered in Ghana using technology to track and better tackle Sickle Cell Disease…